| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 06/30/2010 | CN101757479A Garlic plaster for dispelling deficient fire |
| 06/30/2010 | CN101757451A Natural galenical preparation for promoting nutrition rehabilitation of mucous membrane of animal and preparing method thereof |
| 06/30/2010 | CN101757444A Orally administrated medicine for Chinese traditional treatment of thyroid nodule |
| 06/30/2010 | CN101757416A Chinese herbal prescription for treating tremor |
| 06/30/2010 | CN101757370A Medication for treating thyroiditis and preparation method thereof |
| 06/30/2010 | CN101757303A Plaster for preventing heat stroke |
| 06/30/2010 | CN101757275A Traditional Chinese medicine preparation for treating non-tuberculous hydrothorax |
| 06/30/2010 | CN101757111A Preparation method of Chinese magnoliavine fruit total lignan |
| 06/30/2010 | CN101756979A Fexofenadine hydrochloride orally disintegrating tablet and preparation method thereof |
| 06/30/2010 | CN101756967A Application of methazolamide to preparation of medicaments for preventing and treating acute altitude diseases |
| 06/30/2010 | CN101213953B Method for breeding chick |
| 06/29/2010 | US7745656 Compounds with stabilized S-nitrosyl group and a free alcohol or a free thiol; nitric oxide (NO) releasing; bacteristats; reacting a polythiol or a thioalcohol with a nitrosylating agent (S-Nitrosyl-N-acetyl-D,L-penicillamine (SNAP) and and tert-butylnitrite); |
| 06/29/2010 | US7745604 genetic enhancers comprising the nucleotide sequences that elevates transcription of a heterologous coding sequence in a host cell |
| 06/29/2010 | US7745489 Potent 2-oxo-amide based compounds; abrogating prostaglandin production; low dosage; spinal cord and central nervous system pain |
| 06/29/2010 | US7745488 Therapy for neutropenia as result of radiation therapy; administering colony stimulating factor |
| 06/29/2010 | US7745473 Indole derivative for alkylating specific base sequence of DNA and alkylating agent and drug containing the derivative |
| 06/29/2010 | US7745472 Dimethylsulfamic Acid 2-bromo-4-{[(4-cyano-phenyl)-[1,2,4]triazol-4-ylamino]methyl}phenyl Ester, used as effective sulfatase and/or aromatase inhibitors, and as modulators of cell cycling and modulators of apoptosis; therapy of breast, prostate, ovarian or endometrial cancer |
| 06/29/2010 | US7745450 5-[1-(hydroxymethyl)propyl]amino-7-benzylamino-3-isopropyl(methyl, ethyl)pyrazolo[4,3-d]pyrimidine for inhibiting cell proliferation, cancer, or psoriasis, rheumatoid arthritis, lupus, diabetes, multiple sclerosis, restenosis, polycystic kidney disease, graft rejection, and neurodegerative diseases |
| 06/29/2010 | US7745424 Osteoporosis, bone cancer; antiarthritic agents;paget's disease; antiinflammatory agents |
| 06/29/2010 | US7745420 stability, high effectiveness and low toxicity; for treating pulmonary/respiratory diseases such as cystic fibrosis, asthma, chronic bronchitis, chronic obstructive lung disease, eosinophilic bronchitis |
| 06/29/2010 | US7745388 Peptide for use in the treatment of cell damage caused by ischemia |
| 06/29/2010 | US7745109 Regulation of cell growth by MUC1 |
| 06/29/2010 | US7744927 Methods of promoting hematopoietic and mesenchymal cell proliferation and differentiation |
| 06/29/2010 | US7744921 Liposome loading with metal ions |
| 06/29/2010 | US7744888 Controlling immunology response; autoimmune disease, antiallergens |
| 06/29/2010 | US7744881 for cancer treatment by inducing apoptosis; monoclonal antibodies; drug conjugated with polyoxyethylene glycol or enzyme or radioisotope, fluorescent compound or chemiluminescent compound; genetic engineering; biodrugs; anticarcinogenic agents |
| 06/29/2010 | US7744873 Extracting DNA from a blood or buccal cell sample, PCR, resolution, and identification of differences in sequences between the extracted DNA and PCR primers; drug screening |
| 06/29/2010 | CA2455987C Tetrahydroindolone and purine derivatives linked to arylpiperazines |
| 06/29/2010 | CA2442885C Sulphones which modulate the action of gamma secretase |
| 06/29/2010 | CA2424596C Oral self-emulsifying formulations of pyranone protease inhibitors |
| 06/29/2010 | CA2417942C 2-(4-pyridyl)amino-6-dialkoxyphenyl-pyrido[2,3-d]pyrimidin-7-ones |
| 06/29/2010 | CA2415280C Use of halogenated xanthenes as anti-cancer and anti-bacterial agents |
| 06/29/2010 | CA2409090C Thienodibenzoazulene compounds as tumor necrosis factor inhibitors |
| 06/29/2010 | CA2405521C Macrocyclic ns3-serine protease inhibitors of hepatitis c virus comprising n-cyclic p2 moieties |
| 06/29/2010 | CA2401942C Pharmaceutical compositions for buccal and pulmonary application |
| 06/29/2010 | CA2387841C Cosmetic compositions containing mulberry root extract and retinoids |
| 06/29/2010 | CA2382885C Rhodamine derivatives for photodynamic diagnosis and treatment |
| 06/29/2010 | CA2379734C Treatment of cancers |
| 06/29/2010 | CA2354557C Methods to inactivate n-type calcium channels |
| 06/29/2010 | CA2336593C Methods and compositions for treatment of disorders associated with chlamydial and similar bacterial infection |
| 06/29/2010 | CA2187740C Dna encoding bradykinin b1 receptor |
| 06/29/2010 | CA2187346C Receptor modulating agents and methods relating thereto |
| 06/29/2010 | CA2163976C Methods and compositions for inhibiting cd14 mediated cell activation |
| 06/29/2010 | CA2134030C Soluble interferon .alpha.-receptor, its preparation and use |
| 06/24/2010 | WO2010071190A1 Heparin affinity erythropoietin |
| 06/24/2010 | WO2010071132A1 Peptide for inhibiting skin aging |
| 06/24/2010 | WO2010071051A1 Melanin formation inhibitor and preparation for external application |
| 06/24/2010 | WO2010070183A1 Pharmaceutical composition comprising oleuropein for utilisation in angiogenesis and vasculogenesis induction |
| 06/24/2010 | WO2010005958A3 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase |
| 06/24/2010 | US20100160620 N-pyrazole a2a receptor agonists |
| 06/24/2010 | US20100160450 Methods of reducing 15-f2t-isop levels in mammals |
| 06/24/2010 | US20100160444 Method to inhibit ischemia and reperfusion injury |
| 06/24/2010 | US20100160405 Methods of using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline 1,3-dione |
| 06/24/2010 | US20100160343 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 06/24/2010 | US20100160341 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 06/24/2010 | US20100160305 3, 4, 5 - Substituted Piperidine Compounds |
| 06/24/2010 | US20100160282 Novel diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their use |
| 06/24/2010 | US20100160260 TRBD-Binding Effectors and Methods for Using the Same to Modulate Telomerase Activity |
| 06/24/2010 | US20100160236 Method for Preventing Formation of Trisulfide Derivatives of Polypeptides |
| 06/24/2010 | US20100160227 Signaling peptides |
| 06/24/2010 | US20100160216 Enhanced transport using membrane disruptive agents |
| 06/24/2010 | US20100159439 Method for combined sequential agent delivery and electroporation for cell structures and use thereof |
| 06/24/2010 | US20100159024 Method and apparatus for the extraction and collection of coelomic fluid of sea stars |
| 06/24/2010 | US20100159019 Micelles For Drug Delivery |
| 06/24/2010 | US20100159014 Polymeric micellar clusters and their uses in formulating drugs |
| 06/24/2010 | US20100158997 Blow-molded thin-walled drug delivery capsules |
| 06/24/2010 | US20100158991 Patch package structure |
| 06/24/2010 | US20100158988 Cereal beta glucan compositions, methods of preparation and uses thereof |
| 06/24/2010 | US20100158985 Porous structures of microbial-derived cellulose for in vivo implantation |
| 06/24/2010 | US20100158981 Block Biodegradable Copolymers for Medical Devices |
| 06/24/2010 | US20100158968 Cell-permeant peptide-based inhibitor of kinases |
| 06/24/2010 | US20100158919 Pharmaceutical Composition |
| 06/24/2010 | US20100158879 Expression cassette and vector for transient or stable expression of exogenous molecules |
| 06/24/2010 | US20100158859 Antagonists of il-6 to prevent or treat cachexia, weakness, fatigue, and/or fever |
| 06/24/2010 | US20100158799 Method and composition for bioactive agent release in vivo |
| 06/24/2010 | DE102008064588A1 Nahrungsergänzungsmittel auf der Basis von Pantothensäure Food supplements based on pantothenic acid |
| 06/23/2010 | EP2199299A2 Antisense modulation of survivin expression |
| 06/23/2010 | EP2199295A1 Compounds with 7-member cycle and the pharmaceutical use thereof for preventing and treating diabetes and metabolism syndrome |
| 06/23/2010 | EP2199284A1 Pharmaceutical composition for inhibiting accumulation of amyloid- beta protein |
| 06/23/2010 | EP2199283A1 Prophylactic and/or therapeutic agent for anemia, comprising tetrahydroquinoline compound as active ingredient |
| 06/23/2010 | EP2199282A1 Amide compound |
| 06/23/2010 | EP2198891A1 Method for promoting the expression of p53, and p53 expression promoter for use in the method |
| 06/23/2010 | EP2198888A2 Sustained release of microcrystalline peptide suspensions |
| 06/23/2010 | EP2198882A2 Nucleic acid mucosal immunization |
| 06/23/2010 | EP2198867A1 Pyrimidine-based compounds useful as GSK-3 inhibitors |
| 06/23/2010 | EP1511735B1 Imidazole compounds and their use as ligands of the alpha-" adrenoreceptors |
| 06/23/2010 | EP1511734B1 Compounds, compositions, and methods |
| 06/23/2010 | EP1313497B1 Use of extracts of the cassia alata plant |
| 06/23/2010 | CN1994426B Preparation method, and identification and assaying method of 'Sheng Mai' soft capsule |
| 06/23/2010 | CN1930123B Medicinal composition for prevention or treatment of overactive bladder accompanying nervous disorder |
| 06/23/2010 | CN1919258B Application of schisandra chinensis in the preparation of medicine for preventing and reducing toxic and side effect of antitumor agent |
| 06/23/2010 | CN1910176B Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist |
| 06/23/2010 | CN1895514B Medicine for treating behcet's syndrome |
| 06/23/2010 | CN1871256B Muteins of tear lipocalin |
| 06/23/2010 | CN1620304B Prevention and treatment of oxidative stress disorders by glutathione and phase II detoxification enzymes |
| 06/23/2010 | CN1589166B Stent coated with a sustained-release drug delivery system and method for use thereof |
| 06/23/2010 | CN1446100B Method for treating movement disorder |
| 06/23/2010 | CN101747446A Method for extracting anti-fatigue acidic ginseng polysaccharide |
| 06/23/2010 | CN101747354A Dipeptide boronic acids consisting of beta amino acids, ester compounds and preparation methods and uses thereof |
| 06/23/2010 | CN101747327A Aromatic amide thiazole derivative, preparation method and application thereof |